Tag: Mark Timney

Novartis to acquire The Medicines Company for $9.7bn with eye on inclisiran

pharmanewsdaily- November 25, 2019

Novartis acquisition of The Medicines Company : Swiss drugmaker Novartis signed a deal worth $9.7 billion to acquire US biopharma company The Medicines Company, as ... Read More